Background Image
Table of Contents Table of Contents
Previous Page  6 / 64 Next Page
Information
Show Menu
Previous Page 6 / 64 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 1, January/February 2016

4

AFRICA

Cardiovascular Topics

Filamin C: a novel component of the

KCNE2

interactome

during hypoxia

Annika Neethling, Jomien Mouton, Ben Loos, Valerie Corfield, Carin de Villiers, Craig Kinnear

Abstract

Aim:

KCNE2

encodes for the potassium voltage-gated chan-

nel, KCNE2. Mutations in

KCNE2

have been associated

with long-QT syndrome (LQTS). While

KCNE2

has been

extensively studied, the functions of its C-terminal domain

remain inadequately described. Here, we aimed to elucidate

the functions of this domain by identifying its protein interac-

tors using yeast two-hybrid analysis.

Methods:

The C-terminal domain of KCNE2 was used as bait

to screen a human cardiac cDNA library for putative inter-

acting proteins. Co-localisation and co-immunoprecipitation

analyses were used for verification.

Results:

Filamin C (FLNC) was identified as a putative inter-

actor with KCNE2. FLNC and KCNE2 co-localised within

the cell, however, a physical interaction was only observed

under hypoxic conditions.

Conclusion:

The identification of FLNC as a novel KCNE2

ligand not only enhances current understanding of ion

channel function and regulation, but also provides valuable

information about possible pathways likely to be involved in

LQTS pathogenesis.

Keywords:

LQTS,

KCNE2

, filamin C (FLNC), hypoxia, arrhyth-

mia

Submitted 4/9/14, accepted 17/5/15

Cardiovasc J Afr

2016;

27

: 4–11

www.cvja.co.za

DOI: 10.5830/CVJA-2015-049

Long-QT syndrome (LQTS) is a cardiac repolarisation disorder

with an estimated global prevalence of 1:2 000 to 1:7 000.

1,2

It is characterised by a prolonged QT interval on a surface

electrocardiogram (ECG), with symptoms including syncope,

cardiac arrest and sudden death.

1,3,4

Occasionally, sudden cardiac

death may be the first and only manifestation of LQTS.

5,6

To date, different types of LQTS (LQT1–LQT13), classified

according to the primary disease causal gene, have been

identified, with more than 700 mutations leading to disease

pathogenesis.

7,8

Yet a large number of patients with clinically

diagnosed LQTS have no mutations within any of the known

LQTS causal genes,

9-11

and numerous patients, despite carrying

the same disease-causing mutation, display variable phenotypic

expression and disease penetrance.

12

To complicate matters

further, LQTS can also be acquired through the use of certain

prescribed medications, such as antipsychotics, antidepressants

and antibiotics,

13,14

adding to the growing challenge of clinical

management and treatment of affected individuals.

The

LQT type 6 (LQT6) causal gene,

KCNE2

encoding for

the potassium voltage-gated channel subfamily E member 2

(KCNE2) protein,

15

has been implicated in the development

of inherited, acquired and sporadic forms of LQTS.

13,16-18

This

protein consists of an extracellular N-terminal, a transmembrane

and intracellular C-terminal domain. It comprises the beta-

(

β

) subunits of ion channel complexes and co-assembles with

many different alpha- (

α

) subunits, including the frequently

studied human

Ether-à-go-go

-related (HERG) channel protein

encoded for by the potassium voltage-gated channel, subfamily

H (eag-related), member 2 (

KCNH2

) gene.

15,17,19

In combination

with

KCNE2

, properties of the different ion channel currents

are modulated,

20

assisting in cardiac pacemaker activity and

repolarisation to ensure adequate myocardial recharging and the

maintenance of a regular rhythm.

15,21-23

A unique quality of many cardiac ion channels, including

those containing KCNE2 and HERG, is their ability to adapt

to hypoxic conditions. Hypoxia, defined as the decrease in

available oxygen, causes changes in the electrical characteristics

of ion channels and has been reported to predispose individuals

to fatal arrhythmias.

24-27

Additionally, hypoxic conditions affect

the expression, folding, maturation and trafficking of various

channels.

28-30

In a recent study, it was noted that the expression

of genes from the

KCNE

family (including

KCNE2

) could be

affected by hypoxia in the heart.

31

It has been observed that

acute ischaemic hearts of rats after myocardial infarction show

increased expression of KCNE proteins, attributable to hypoxia.

31

The intricacy of processes causing and modifying cardiac

arrhythmias highlights the importance of identifying the protein

DST/NRF Centre of Excellence in Biomedical Tuberculosis

Research, SA MRC Centre for Tuberculosis Research,

Division of Molecular Biology and Human Genetics,

Department of Biomedical Sciences, Faculty of Medicine

and Health Sciences, Stellenbosch University, South Africa

Annika Neethling, MSc,

aneethling@sun.ac.za

Jomien Mouton, PhD

Valerie Corfield, PhD

Carin de Villiers, PhD

Craig Kinnear, PhD

Department of Physiological Sciences, Faculty of Science,

Stellenbosch University, Stellenbosch, South Africa

Ben Loos, PhD